Total Payments
$135,782
2024 Payments
$2,497
Companies
80
Transactions
701
Medicare Patients
20,435
Medicare Billing
$2.8M
Payment Breakdown by Category
Consulting$69,856 (51.4%)
Other$49,572 (36.5%)
Food & Beverage$14,561 (10.7%)
Travel$1,302 (1.0%)
Education$490.74 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $69,856 | 40 | 51.4% |
| Current or prospective ownership or investment interest | $49,322 | 4 | 36.3% |
| Food and Beverage | $14,561 | 635 | 10.7% |
| Travel and Lodging | $1,302 | 4 | 1.0% |
| Education | $490.74 | 16 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $50,003 | 14 | $0 (2024) |
| Ethicon Inc. | $35,032 | 24 | $0 (2023) |
| Medical Device Business Services, Inc. | $22,534 | 14 | $0 (2023) |
| Auris Health, Inc. | $11,567 | 8 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $1,399 | 47 | $0 (2024) |
| Astellas Pharma US Inc | $1,352 | 78 | $0 (2024) |
| Ethicon Endo-Surgery Inc. | $1,100 | 6 | $0 (2017) |
| Antares Pharma, Inc. | $899.62 | 59 | $0 (2024) |
| PFIZER INC. | $849.20 | 38 | $0 (2024) |
| ABBVIE INC. | $803.98 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,497 | 96 | Sumitomo Pharma America, Inc. ($319.52) |
| 2023 | $5,929 | 94 | Ethicon Inc. ($2,340) |
| 2022 | $7,281 | 89 | Ethicon Inc. ($3,900) |
| 2021 | $19,938 | 69 | Ethicon Inc. ($15,435) |
| 2020 | $16,117 | 62 | Ethicon Inc. ($13,338) |
| 2019 | $25,339 | 76 | Boston Scientific Corporation ($20,181) |
| 2018 | $43,714 | 104 | Boston Scientific Corporation ($27,705) |
| 2017 | $14,968 | 111 | Medical Device Business Services, Inc. ($11,505) |
All Payment Transactions
701 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Prostate cancer | ||||||
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: HORMONE THERAPY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Oncology | ||||||
| 12/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $113.97 | General |
| 12/06/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: UROLOGY | ||||||
| 11/21/2024 | COLOPLAST CORP | — | Food and Beverage | In-kind items and services | $39.74 | General |
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $23.55 | General |
| 11/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA, BALVERSA | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Oncology | ||||||
| 11/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Olympus America Inc. | Bovie (Device) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Urology Gynecology | ||||||
| 10/11/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/03/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $80.45 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 5,519 | 250,214 | $3.6M | $728,509 |
| 2022 | 31 | 5,320 | 210,659 | $3.2M | $671,539 |
| 2021 | 32 | 5,012 | 194,436 | $3.3M | $699,322 |
| 2020 | 33 | 4,584 | 157,956 | $3.0M | $653,404 |
Total Patients
20,435
Total Services
813,265
Medicare Billing
$2.8M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 723 | 1,303 | $599,505 | $148,244 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,007 | 1,837 | $597,025 | $145,324 | 24.3% |
| J3145 | Injection, testosterone undecanoate, 1 mg | Office | 2023 | 30 | 72,000 | $257,755 | $103,433 | 40.1% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 25 | 25 | $374,350 | $80,463 | 21.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 52 | 376 | $266,635 | $49,562 | 18.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 151 | 185 | $138,750 | $44,699 | 32.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 1,115 | 1,833 | $357,435 | $19,802 | 5.5% |
| 55875 | Insertion of needle or tube into prostate for radiation therapy | Facility | 2023 | 27 | 27 | $68,677 | $19,394 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $61,425 | $14,055 | 22.9% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 16 | 3,840 | $43,929 | $12,487 | 28.4% |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | Facility | 2023 | 17 | 17 | $102,000 | $11,213 | 11.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 16 | 16 | $40,436 | $8,643 | 21.4% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 20 | 20 | $22,840 | $7,552 | 33.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 94 | 515 | $33,628 | $7,003 | 20.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 445 | 570 | $148,200 | $6,799 | 4.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $25,011 | $6,436 | 25.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 54 | 140 | $16,531 | $5,001 | 30.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 41 | 41 | $30,963 | $4,598 | 14.9% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 85 | 165,400 | $109,736 | $3,667 | 3.3% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 41 | $15,375 | $3,617 | 23.5% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 18 | 21 | $10,500 | $3,022 | 28.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 623 | 877 | $10,524 | $2,978 | 28.3% |
| 52214 | Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope | Facility | 2023 | 17 | 20 | $43,680 | $2,692 | 6.2% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 514 | 662 | $18,536 | $2,601 | 14.0% |
| 77021 | Review by radiologist of mri guidance for needle placement | Facility | 2023 | 40 | 41 | $62,853 | $2,576 | 4.1% |
About Dr. Chih-Hsin Wen, MD
Dr. Chih-Hsin Wen, MD is a Urology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477517084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chih-Hsin Wen, MD has received a total of $135,782 in payments from pharmaceutical and medical device companies, with $2,497 received in 2024. These payments were reported across 701 transactions from 80 companies. The most common payment nature is "Consulting Fee" ($69,856).
As a Medicare-enrolled provider, Wen has provided services to 20,435 Medicare beneficiaries, totaling 813,265 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Oakland, CA
- Active Since 04/12/2006
- Last Updated 02/10/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1477517084
Products in Payments
- GENERAL THERAPIES (Device) $27,374
- Monarch Platform (Device) $21,700
- GENERAL THERAPIES (Device) $20,151
- Monarch (Device) $11,550
- CERTUS 140 MICROWAVE ABLATION SYSTEM (Device) $5,843
- Certus 140 (Device) $5,563
- GENERAL - THERAPIES (Device) $1,797
- PROVENGE (Drug) $1,416
- XTANDI (Drug) $962.95
- AquaBeam Robotic System (Device) $551.87
- BOTOX (Biological) $547.66
- GEMTESA (Drug) $519.68
- XYOSTED (Drug) $480.19
- Myrbetriq (Drug) $464.77
- NOCDURNA (Drug) $460.84
- AVEED (Biological) $457.79
- AMS (Device) $389.43
- LUPRON DEPOT (Drug) $370.28
- XIAFLEX (Biological) $360.93
- JELMYTO (Drug) $314.95
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Oakland
Dr. Shu Pan, M.d, M.D
Urology — Payments: $16,498
Urology $16,498
Qingwei Yan, M.d, M.D
Urology — Payments: $12,264
Urology $12,264
Christopher Welty, Md, MD
Urology — Payments: $10,061
Urology $10,061
Dr. Dawud Lankford, M.d, M.D
Urology — Payments: $8,203
Urology $8,203
Dr. Christopher Loftus, M.d, M.D
Urology — Payments: $4,098
Urology $4,098
Phillip Ross, Md, MD
Urology — Payments: $2,539
Urology $2,539